JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2006, 55(1):24-28

Prophylactic Administration of Homoisoflavonoid in Ischemic-Reperfusion Damage of the Renal Tissue in the Laboratory Rat

L. Bartošíková1, J. Nečas1, V. Suchý2, D. Jankovská2, E. Janoštíková1, T. Bartošík3, J. Klusáková4, T. Florian1, M. Frydrych1, P. Kollár1, J. Krčmář1, V. Strnadová1, P. Fráňa5
1 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav humánní farmakologie a toxikologie
2 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav přírodních léčiv
3 Úrazová nemocnice v Brně
4 Lékařská fakulta Masarykovy univerzity v Brně, Patologicko-anatomický ústav
5 Fakultní nemocnice U sv. Anny v Brně, II. Interní klinika

The study aimed to examine the antioxidizing effect of homoisoflavonoid in prophylactic administration under the conditions of renal ischemia-reperfusion in the laboratory rat. The pathological model for the in vivo experiment was unilateral renal ischemia-reperfusion of the laboratory rat. The animals were randomized into 5 groups. Homoisoflavonoid was administered to treated groups orally in doses of 5, 10 and 20 mg/kg once a day in 0.5% Avicel solution. The placebo group received Avicel only, and the intact group was without medication and intervention. On day 15 of the experiment, renal tissue ischemia/reperfusion (60/10 mins) was induced in the treated and placebo groups. Then the animals were exsanguinated, biochemical parameters in the blood (superoxidismutase, glutathionperoxidase, total antioxidizing capacity and malondialdehyde) were assayed, and renal samples were withdrawn for histopathological examination. A biochemical examination demonstrated a dependence of the effect of homoisoflavonoid on the dose administered. An obvious effect was demonstrated in the values of GSHPx, AOC, and MDA. On the other hand, a negative dependence was found between the dose of administered homoisoflavonoid and SOD and GSHPx values. The results of biochemical examination correlate with the histopathological pictures of the renal tissue and support the assumption about a protective effect of homoisoflavonoid under the conditions of artificially induced pathological state - renal tissue ischemia-reperfusion.

Keywords: antioxidants; homoisoflavonoid; ischemia-reperfusion; kidney

Received: July 2, 2005; Accepted: October 25, 2005; Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartošíková L, Nečas J, Suchý V, Jankovská D, Janoštíková E, Bartošík T, et al.. Prophylactic Administration of Homoisoflavonoid in Ischemic-Reperfusion Damage of the Renal Tissue in the Laboratory Rat. Čes. slov. farm. 2006;55(1):24-28.
Download citation

References

  1. Sies, H.: Atemw Lungenkrkh 1991; 17 (Suppl. 1), 16.
  2. Rotilio, G..: In: Procedings of the 6th European Congress on Biotechnology (Alberghina, L., Frontali, L., Sensi, P., ed.) Elsevier Science, 1994, s. 763.
  3. Nečas, J., Bartošíková, L., Drápelová, L. et al.: Vnitř. Lék., 1997; 43, 707-711.
  4. Bartošíková, L., Nečas, J., Pavlíček, V. et al.: Čes. slov. Farm., 1998; 47, 151-154
  5. Calomme, M., Pieters, L., Vlietinck, A., Vanden Berghe, D.: Planta Med 1996; 62, 222- 226. Go to original source... Go to PubMed...
  6. Read, M. A..: Am. J. Pathol., 1995; 147, 235-237. Go to original source...
  7. Perez, R. M., Zaval, M. A., Perez, S., Perez, C..: Phytomed., 1998; 5, 55-57.
  8. Yamamura, S., Ozawa, K., Ohtani, K. et al.: Phytochem., 1998; 48, 131-136. Go to original source...
  9. Jovanovic, S. V., Steenken, S., Tosic, M. et al.: J. Am. Chem. Soc., 1994; 116, 4846-4851. Go to original source...
  10. Rice-Evans, C. A., Miller, N, J., Bolwell, P. G. et al.: Free Rad. Res., 1995; 22, 375-383. Go to original source... Go to PubMed...
  11. Kubínová, R., Suchý, V.: Čes. slov. Farm., 1999; 48, 914.
  12. Catapano, A. L.:: Angiology, 1997; 48, 39-44. Go to original source... Go to PubMed...
  13. Uchiyama, M., Mihara, M.:: Anal. Biochem., 1978; 3, 271-278. Go to original source... Go to PubMed...
  14. Singh, D., Chopra, K.: Pharmacol. Res., 2004; 50, 187193. Go to original source... Go to PubMed...
  15. Gurel, A., Armutcu, F., Sahin, S. et al.: Clin. Chim. Acta, 2004; 339, 33-41. Go to original source... Go to PubMed...
  16. Lien, Y. H., Lai, L. W., Silva, A. L.: Life Sci., 2003; 74, 543-552. Go to original source... Go to PubMed...
  17. Bosetti, F., Baracca, A., Lenaz, G., Solaini, G.: FEBS Letters, 2004; 563, 161-164. Go to original source... Go to PubMed...
  18. Racek, J., Eiselt, J., Holeček, V. et al.: Klin. Biochem. Metab., 1997; 26, 92-97.
  19. Mimic-Oka, J., Simic, T., Ekmescic, V., Dragicevic, P.: Clin. Nephrol., 1995; 1, 44-48.
  20. Racek, J., Veselá, E., Holeček, V., Třeška, V..: Klin. Biochem. Metab., 1995; 24 (Suppl.), 4-6.
  21. Durak, I., Kacmaz, M., Elgun, S., Ozburk, H. S.: Med. Princ. Pract., 2004; 13, 84-87. Go to original source... Go to PubMed...
  22. Bonomini, M., Albertazzi, A.: Artif. Organs., 1995; 19, 443-448. Go to original source... Go to PubMed...
  23. Toborek, M., Wasik, T., Drozdz, M. et al.: Metabolism, 1992; 41, 1299-1232. Go to original source... Go to PubMed...
  24. Jackson, P., Loughrey, C. M., Lightbody, J. H. et al.: Clin. Chem., 1995; 41, 1135-1138. Go to original source...
  25. Roselaar, S. E., Naznat, N. B., Winyard P. G. et al.: Kidney Int., 1995; 48, 199-206. Go to original source... Go to PubMed...
  26. Lee, P. H., Chung, Y. C., Hu, R. H. et al.: Transpl. Proc., 1992; 24, 1353-1354.
  27. Zurovsky, Y., Eligal, Z., Grossman, S.: Exp. Toxic. Path., 1995; 47, 471-478. Go to original source... Go to PubMed...
  28. Bartošová, L., Frydrych, M., Mokrý, P. et al.: Pharmazie, 2003; 58, 841-842.
  29. Bisset, N. G., Houghton, P. J., Hylands, P. J.:: In: The medicinal plant industry (Wisekera, R. O. B. ed.), London, CRC Press, 1991, s. 115.




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.